News and Trends 4 Jul 2023
Exeliom Biosciences closes €24M financing for lead candidate
Exeliom Biosciences has completed a €24 million ($26 million) Series A to progress the clinical development of its therapeutic pipeline. This includes several clinical trials of EXL01, a novel immunotherapy…